Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 November 2020

The UFS SRC Elections will be held from 01 to 04 December 2020 for the QwaQwa and South Campus. The Bloemfontein Campus SRC elections for the elective portfolios will be held in 2021. 

• The window for the nomination of candidates for the CSRC elective portfolios has closed and the final candidate list of candidates is now available on the election website.

• Candidates’ on the final list may therefore conduct their campaigns. Candidates’ campaigns must be within the prescripts of the UFS SRC Election Code of Conduct. 

• Nominations for ex-officio candidates have since closed. In this regard, the final list of candidates will be published on election website on 25 November 2020 

• Student Council Elections for the ex-officio portfolios will be held from 26 to 30 November 2020. To this effect, an invitation to respective student council meetings will be sent out via student emails. 

• Manifesto launches will take place via webinars between 25 and 30 November 2020. A detailed schedule will be made available via the election website.   

KDBS Consulting (Pty) Ltd has been appointed to oversee and manage the SRC elections 2020/2021 as the Independent Chief Elections Administrator. A website has been launched to provide up-to-date information regarding these elections and all processes related to it. The website address is https://www.ufs-srcelection.co.za.

For any queries related to the elections, you can email the Chief Election Administrator at info@ufs-srcelection.co.za  or you can call the election helpdesk at +27 0 800 061 052 toll-free.   

Please look out for election-specific notifications via SMS or your UFS4Life student emails.   

News Archive

Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Description: Prof Riaz Seedat Tags: Prof Riaz Seedat

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS

Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.

He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.

Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.

The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.

Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.

“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.

“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept